Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C, Yu NY, Shan J, Bhangoo RS, Daniels TB, Chiang JS, Ding X, Lara P, Patrick CL, Archuleta JP, DeWees T, Hu Y, Schild SE, Bues M, Sio TT, Liu W. Liu C, et al. Among authors: schild se. Med Phys. 2019 Nov;46(11):4755-4762. doi: 10.1002/mp.13809. Epub 2019 Sep 21. Med Phys. 2019. PMID: 31498885
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.
Schild SE, McGinnis WL, Graham D, Hillman S, Fitch TR, Northfelt D, Garces YI, Shahidi H, Tschetter LK, Schaefer PL, Adjei A, Jett J. Schild SE, et al. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1106-11. doi: 10.1016/j.ijrobp.2006.02.046. Epub 2006 May 26. Int J Radiat Oncol Biol Phys. 2006. PMID: 16730134 Clinical Trial.
Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer.
Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Vora SA, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1053-8. doi: 10.1016/j.ijrobp.2007.01.043. Epub 2007 Mar 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17398023
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer.
Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA; North Central Cancer Treatment GroupThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic. Schild SE, et al. Cancer. 2007 Jul 15;110(2):363-8. doi: 10.1002/cncr.22780. Cancer. 2007. PMID: 17542000 Free article. Clinical Trial.
598 results